Open Access

Ginsenoside Rb1 prevents steroid‑induced avascular necrosis of the femoral head through the bone morphogenetic protein‑2 and vascular endothelial growth factor pathway

  • Authors:
    • Junwu Ye
    • Daiqin Wei
    • Lin Peng
    • Tianmin Chang
  • View Affiliations

  • Published online on: August 6, 2019     https://doi.org/10.3892/mmr.2019.10553
  • Pages: 3175-3181
  • Copyright: © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

At present, the molecular mechanism underlying the protective effect of Ginsenoside Rb1 remains unclear. The present study was designed to investigate whether Ginsenoside Rb1 weakened the steroid‑induced avascular necrosis of the femoral head (SANFH) and to explore the possible mechanisms of the above effects. As a result, it was revealed that Ginsenoside Rb1 was protective against steroid‑induced avascular necrosis and inhibited serum osteocalcin in a rat model of SANFH. Ginsenoside Rb1 reduced inflammation, oxidative stress and bone cell apoptosis in a rat model of SANFH. Furthermore, Ginsenoside Rb1 attenuated trabecula parameters, total cholesterol and low density lipoprotein/high density lipoprotein in SANFH rat. Additionally, Ginsenoside Rb1 significantly reversed alkaline phosphatase and osteocalcin activities, vascular endothelial growth factor (VEGF) receptor, VEGF, Runt related transcription factor 2 (Runx2) and bone morphogenetic protein (BMP)‑2 protein expression in SANFH rat. Collectively, the present study demonstrated that Ginsenoside Rb1 attenuated SANFH through the VEGF/RUNX2/BMP‑2 signaling pathway.

References

1 

Seldes RM, Tan V, Duffy G, Rand JA and Lotke PA: Total knee arthroplasty for steroid-induced osteonecrosis. J Arthroplasty. 14:533–537. 1999. View Article : Google Scholar : PubMed/NCBI

2 

Moriya M, Uchiyama K, Takahira N, Fukushima K, Yamamoto T, Hoshi K, Itoman M and Takaso M: Evaluation of bipolar hemiarthroplasty for the treatment of steroid-induced osteonecrosis of the femoral head. Int Orthop. 36:2041–2047. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Nagasawa K, Tada Y, Koarada S, Tsukamoto H, Horiuchi T, Yoshizawa S, Murai K, Ueda A, Haruta Y and Ohta A: Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant. Lupus. 15:354–357. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Khatami PG, Soleimani A, Sharifi N, Aghadavod E and Asemi Z: The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. J Clin Lipidol. 10:922–929. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Bouchi R, Nakano Y, Fukuda T, Takeuchi T, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T and Ogawa Y: Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: A randomized control trial. Endocr J. 64:269–281. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Sulaj A, Kopf S, Grone E, Gröne HJ, Hoffmann S, Schleicher E, Häring HU, Schwenger V, Herzig S, Fleming T, et al: ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy. J Diabetes Complications. 31:1058–1065. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Bahmani F, Kia M, Soleimani A, Mohammadi AA and Asemi Z: The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: A randomised, double-blind, placebo-controlled trial. Br J Nutr. 116:1222–1228. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, Wang J, Xiong YQ, Hui DY, Woods SC and Liu M: Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res. 54:1430–1438. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Wang M, Chen Y, Xiong Z, Yu S, Zhou B, Ling Y, Zheng Z, Shi G, Wu Y and Qian X: Ginsenoside Rb1 inhibits free fatty acidsinduced oxidative stress and inflammation in 3T3L1 adipocytes. Mol Med Rep. 16:9165–9172. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Zhou F, Zhang P and Chen X, Yan J, Yao J, Yu Z and Chen X: Ginsenoside Rb1 protects the intestinal mucosal barrier following peritoneal air exposure. Exp Ther Med. 12:2563–2567. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Powell C, Chang C and Gershwin ME: Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis. Clin Rev Allergy Immunol. 41:102–113. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Tian L, Wen Q, Dang X, You W, Fan L and Wang K: Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis. BMC Musculoskelet Disord. 15:182014. View Article : Google Scholar : PubMed/NCBI

14 

Li J, Fan L, Yu Z, Dang X and Wang K: The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads. Exp Biol Med (Maywood). 240:273–280. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Xiang Y, Zhao J, Zhao M and Wang K: Allicin activates autophagic cell death to alleviate the malignant development of thyroid cancer. Exp Ther Med. 15:3537–3543. 2018.PubMed/NCBI

16 

Zhu Y, Hu C, Zheng P, Miao L, Yan X, Li H, Wang Z, Gao B and Li Y: Ginsenoside Rb1 alleviates aluminum chloride-induced rat osteoblasts dysfunction. Toxicology. 368-369:183–188. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Yuan HF, Pan JF, Li S, Guo CA, Liu SH and Yan ZQ: Protective effects of total saponins of panax notoginseng on steroid-induced avascular necrosis of the femoral head in vivo and in vitro. Evid Based Complement Alternat Med. 2015:1656792015. View Article : Google Scholar : PubMed/NCBI

18 

Patil AS, Sable RB and Kothari RM: Occurrence, biochemical profile of vascular endothelial growth factor (VEGF) isoforms and their functions in endochondral ossification. J Cell Physiol. 227:1298–1308. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Seamon J, Wang X, Cui F, Keller T, Dighe AS, Balian G and Cui Q: Adenoviral delivery of the VEGF and BMP-6 genes to rat mesenchymal stem cells potentiates osteogenesis. Bone Marrow Res. 2013:7375802013. View Article : Google Scholar : PubMed/NCBI

20 

Lan TH, Xu DP, Huang MT, Song JX, Wu HL and Li M: Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF.p38MAPK and SDF-1/CXCR4 activation. Sci Rep. 7:130612017. View Article : Google Scholar : PubMed/NCBI

21 

Matsumoto T, Yamada A, Aizawa R, Suzuki D, Tsukasaki M, Suzuki W, Nakayama M, Maki K, Yamamoto M, Baba K and Kamijo R: BMP-2 induced expression of Alx3 that is a positive regulator of osteoblast differentiation. PLoS One. 8:e687742013. View Article : Google Scholar : PubMed/NCBI

22 

Li H, Johnson NR, Usas A, Lu A, Poddar M, Wang Y and Huard J: Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells. Stem Cells Transl Med. 2:667–677. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Geng S, Sun B, Lu R and Wang J: Coleusin factor, a novel anticancer diterpenoid, inhibits osteosarcoma growth by inducing bone morphogenetic protein-2-dependent differentiation. Mol Cancer Ther. 13:1431–1441. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Mariscal-Munoz E, Costa CA, Tavares HS, Bianchi J, Hebling J, Machado JP, Lerner UH and Souza PP: Osteoblast differentiation is enhanced by a nano-to-micro hybrid titanium surface created by Yb:YAG laser irradiation. Clin Oral Investig. 20:503–511. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Martin A, Xiong J, Koromila T, Ji JS, Chang S, Song YS, Miller JL, Han CY, Kostenuik P, Krum SA, et al: Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association. Bone. 75:96–104. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Yang S, Xu H, Yu S, Cao H, Fan J, Ge C, Fransceschi RT, Dong HH and Xiao G: Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts. J Biol Chem. 286:19149–19158. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Zhu L and Xu PC: Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Biochem Biophys Res Commun. 432:612–617. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ye, J., Wei, D., Peng, L., & Chang, T. (2019). Ginsenoside Rb1 prevents steroid‑induced avascular necrosis of the femoral head through the bone morphogenetic protein‑2 and vascular endothelial growth factor pathway. Molecular Medicine Reports, 20, 3175-3181. https://doi.org/10.3892/mmr.2019.10553
MLA
Ye, J., Wei, D., Peng, L., Chang, T."Ginsenoside Rb1 prevents steroid‑induced avascular necrosis of the femoral head through the bone morphogenetic protein‑2 and vascular endothelial growth factor pathway". Molecular Medicine Reports 20.4 (2019): 3175-3181.
Chicago
Ye, J., Wei, D., Peng, L., Chang, T."Ginsenoside Rb1 prevents steroid‑induced avascular necrosis of the femoral head through the bone morphogenetic protein‑2 and vascular endothelial growth factor pathway". Molecular Medicine Reports 20, no. 4 (2019): 3175-3181. https://doi.org/10.3892/mmr.2019.10553